MNKD Q3 2025 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+17.2% YoY

Gross Profit

$62M75.4% margin

Operating Income

$19M22.9% margin

Net Income

$8M9.7% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$22M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$495M

Total Liabilities

$539M

Stockholders' Equity

-$45M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$70M	+17.2%
Gross Profit	$62M	$52M	+19.0%
Operating Income	$19M	$13M	+47.1%
Net Income	$8M	$12M	-30.9%

Revenue Segments

Product Revenue

$48M59%

Royalty

$33M41%

Service

$537,0001%